Skip to main content
Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients

Fig. 2

T1-weighted gadolinium-enhanced brain MRI of a 58-year-old man. Oligoprogression lesions were found in the left occipital (A), left frontal lobe (B), and right cerebellum (C). After left occipital tumor excision and adjuvant whole-brain radiotherapy, the patient changed from afatinib to osimertinib. Lesions were controlled well after a 6-month image follow-up (D, E, F)

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us